Research and Markets: Portal Hypertension Therapeutics: Pipeline Assessment and Market Forecasts to 2019
March 15 2012 - 11:11AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/039aba/portal_hypertensio)
has announced the addition of new report "Portal Hypertension
Therapeutics - Pipeline Assessment and Market Forecasts to 2019" to
their offering.
The Portal Hypertension Therapeutics Market is Forecast to Show
Slow Growth
The global portal hypertension therapeutics market is estimated
to be valued at $1.7 billion in 2011. It is expected to grow to
$1.9 billion at a Compound Annual Growth Rate (CAGR) of 2.0% by
2019. This slow growth is due to the slow increase in the prevalent
population, the domination of the market by generics and low
likelihood of new product launches during the forecast period.
Current Treatment Options Create Significant Unmet Need in the
Market
GlobalData's analysis found that the unmet need in the portal
hypertension market is significant, which implies that the market
is not well served by the current treatment options. There are no
drugs approved for the treatment of portal hypertension. The market
is dominated by off-label generic drugs. Beta-blockers are the
drugs mainly used for treatment of portal hypertension. However,
due to contraindications and side effects beta-blocker therapy is
discontinued in many patients. Therefore there is a need for novel
drugs with better safety and efficacy profiles to capture the
untapped market.
This report is an essential source of information and analysis
on the global Portal Hypertension Therapeutics market. The report
identifies the key trends shaping and driving the global Portal
Hypertension Therapeutics market. The report also provides insights
on the prevalent competitive landscape and the emerging players
expected to significantly alter the market positioning of the
current market leaders. Most importantly, the report provides
valuable insights on the pipeline products within the global Portal
Hypertension Therapeutics sector. This report is built using data
and information sourced from proprietary databases, primary and
secondary research and in-house analysis by a team of industry
experts.
Key Topics Covered:
- Portal Hypertension Cirrhosis Therapeutics - Introduction
- Portal Hypertension Therapeutics - Market Characterization
- Portal Hypertension Therapeutics - Competitive Assessment
- Portal Hypertension Therapeutics - Pipeline Assessment
- Portal Hypertension Therapeutics - Clinical Trials Mapping
- Portal Hypertension Therapeutics - Strategic Assessment
- Portal Hypertension Therapeutics - Future Players
Companies Mentioned:
- Chiasma (Israel) Ltd.
- Dong-A Pharmaceutical Co Ltd (Dong-A)
For more information visit
http://www.researchandmarkets.com/research/039aba/portal_hypertensio